O Efeito da Doença de Coronavírus 2019 nas Doenças Cardiovasculares
Lütfü Aşkın, Okan Tanrıverdi, Hüsna Şengül Aşkın
Abstract
Coronavirus disease 2019 (COVID-19) is a global pandemic affecting the world, seen in more than 1,300,000 patients. COVID-19 acts through the angiotensin-converting enzyme 2 (ACE2) receptor. Cardiovascular comorbidities are more common with COVID-19, and nearly 10% of cases develop myocarditis (22% of critical patients). Further research is needed to continue or discontinue ACE inhibitors and angiotensin receptor blockers, which are essential in hypertension and heart failure in COVID-19. Intensive research is promising for the treatment and prevention of COVID-19.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Angiotensin Receptor Blockers2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MyocarditisPandemicCoronavirus InfectionsInternal medicineGynecologyAngiotensin-converting enzymeDiseaseVirologyBlood pressureInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Healthcare during COVID-19 Pandemic